SAB Biotherapeutics (SABS) Revenue (2021 - 2024)
SAB Biotherapeutics' Revenue came in at $114,698 for Q4 2024, down 62.4% from $305,011 a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Revenue (2021 - 2024) Analysis & Trends
For FY2024, SAB Biotherapeutics' Revenue was $1.32 million, down 40.9% from FY2023.
- Revenue has declined in each of the last three years, with a four-year compound annual growth rate of -60.7% (FY2020 to FY2024).
- Going back by year, Revenue was $2.24 million in FY2023 (-90.6%), $23.9 million in FY2022 (-60.7%), $60.88 million in FY2021 (+10.2%) and $55.24 million in FY2020.
- The Q4 2024 figure represents the lowest quarterly Revenue since Q2 2023.
- Year-over-year, Revenue increased in two of the last seven quarters, with an average decline of 19.5%.
- The fastest year-over-year change in Revenue over five years came in Q2 2024 (growth of 207.7%), and the weakest in Q2 2023 (a decline of 98.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 114,698.00 |
| Jun 30, 2024 | 263,137.00 |
| Mar 31, 2024 | 944,575.00 |
| Dec 31, 2023 | 305,011.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 85,518.00 |
| Mar 31, 2023 | 581,101.00 |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Mar 31, 2022 | 11.80 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Sep 30, 2021 | 14.68 Mn |
| Jun 30, 2021 | 18.21 Mn |
| Mar 31, 2021 | 16.93 Mn |
API Access
SAB Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();